Title:
ＥＧＦＲキナーゼ阻害剤およびその製造方法と使用
Document Type and Number:
Japanese Patent JP6752283
Kind Code:
B2
Abstract:
The present invention provides an EGFR kinase inhibitor and a preparation method and use thereof. Specifically, the present invention provides a compound as shown in formula (I), the definition of each group therein being as described in the description. Said compound is an efficient EGFR inhibitor.
Inventors:
Ma, Dawe
Yu, Chang
Yen Inn
Xia, Hwang
Tsai, Donpo
One, Kyrian
Jean, Chen
Shea, Shanfa
Yu, Chang
Yen Inn
Xia, Hwang
Tsai, Donpo
One, Kyrian
Jean, Chen
Shea, Shanfa
Application Number:
JP2018535217A
Publication Date:
September 09, 2020
Filing Date:
July 11, 2016
Export Citation:
Assignee:
ZHEJIANG BOSSAN PHARMACEUTICAL CO. LTD.
International Classes:
C07D239/48; A61K31/506; A61P35/00; A61P43/00; C07D401/12; C07D401/14
Domestic Patent References:
| JP2013541561A | ||||
| JP2011526299A | ||||
| JP2013515786A |
Foreign References:
| WO2015117547A1 | ||||
| CN104860890A |
Attorney, Agent or Firm:
Seiji Ohno
Yuko Matsuniya
Umeda Shinsuke
Hiroshi Morita
Tomoe Konno
Nobuto Oki
Yuko Matsuniya
Umeda Shinsuke
Hiroshi Morita
Tomoe Konno
Nobuto Oki